Cyclacel announces reverse stock split
Cyclacel Pharmaceuticals announced that effective May 27, 2016, the Company will effect a one-for-twelve reverse stock split of its outstanding common stock. The reverse stock split was unanimously approved by the Company's Board of Directors and stockholders May 26, 2016. May 27, 2016